1. Home
  2. OPY vs CTKB Comparison

OPY vs CTKB Comparison

Compare OPY & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPY
  • CTKB
  • Stock Information
  • Founded
  • OPY 1881
  • CTKB 1990
  • Country
  • OPY United States
  • CTKB United States
  • Employees
  • OPY N/A
  • CTKB N/A
  • Industry
  • OPY Investment Bankers/Brokers/Service
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • OPY Finance
  • CTKB Health Care
  • Exchange
  • OPY Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • OPY 651.2M
  • CTKB 718.8M
  • IPO Year
  • OPY N/A
  • CTKB 2021
  • Fundamental
  • Price
  • OPY $62.61
  • CTKB $5.12
  • Analyst Decision
  • OPY
  • CTKB Strong Buy
  • Analyst Count
  • OPY 0
  • CTKB 2
  • Target Price
  • OPY N/A
  • CTKB $9.25
  • AVG Volume (30 Days)
  • OPY 20.3K
  • CTKB 760.6K
  • Earning Date
  • OPY 01-31-2025
  • CTKB 02-27-2025
  • Dividend Yield
  • OPY 1.14%
  • CTKB N/A
  • EPS Growth
  • OPY 145.95
  • CTKB N/A
  • EPS
  • OPY 6.37
  • CTKB N/A
  • Revenue
  • OPY $1,344,505,000.00
  • CTKB $201,210,000.00
  • Revenue This Year
  • OPY N/A
  • CTKB $7.26
  • Revenue Next Year
  • OPY N/A
  • CTKB $8.20
  • P/E Ratio
  • OPY $9.89
  • CTKB N/A
  • Revenue Growth
  • OPY 13.93
  • CTKB 9.88
  • 52 Week Low
  • OPY $36.93
  • CTKB $4.66
  • 52 Week High
  • OPY $73.12
  • CTKB $9.33
  • Technical
  • Relative Strength Index (RSI)
  • OPY 37.44
  • CTKB 37.48
  • Support Level
  • OPY $62.35
  • CTKB $5.18
  • Resistance Level
  • OPY $66.38
  • CTKB $5.48
  • Average True Range (ATR)
  • OPY 1.74
  • CTKB 0.27
  • MACD
  • OPY -0.60
  • CTKB 0.01
  • Stochastic Oscillator
  • OPY 4.06
  • CTKB 27.85

About OPY Oppenheimer Holdings Inc. (DE)

Oppenheimer Holdings Inc conducts activities in the securities industry. The company is involved in retail securities brokerage, investment banking (both corporate and public finance), institutional sales and trading, market-making, research, trust services, and investment advisory and asset management services. The company has three segments: private client, asset management, and capital markets. The Private Client segment, commissions and a proportionate amount of fee income earned on assets under management ("AUM"), net interest earnings on client margin loans and cash balances, fees from money market funds, and custodian fees. The company generates the majority of its revenue from the Americas, with the rest from Europe, the Middle East, and Asia.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: